Fingerprint
Dive into the research topics of 'Phase 1/2 dose escalating study of twice-monthly pemetrexed and gemcitabine in patients with advanced cancer and non-small cell lung cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically